US2021228802A1PendingUtilityA1

Systems and methods for automatic termination of flow due to needle dislodgement

Assignee: HEMOTEK MEDICAL INCORPORATEDPriority: Apr 11, 2014Filed: Apr 16, 2021Published: Jul 29, 2021
Est. expiryApr 11, 2034(~7.7 yrs left)· nominal 20-yr term from priority
A61M 5/158A61M 2005/1588A61M 2005/1586A61M 39/281A61M 5/16813A61M 2205/276
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods for automatic flow termination for fluid delivery, including a housing configured for coupling a fluid delivery tube to a needle configured for subcutaneous delivery of fluid within a tissue of a patient and a spring-loaded activation mechanism having a first orientation corresponding to a condition where the housing is disposed substantially adjacent to the tissue and the needle lodged within the tissue and a second orientation corresponding to a condition where the housing is disposed away from the tissue or the needle being dislodged from the tissue. A flow termination mechanism is coupled to the activation mechanism and having an open configuration allowing flow from the fluid delivery tube to the needle when the activation mechanism is in the first orientation and a closed configuration substantially terminating flow from the fluid delivery tube to the needle when the activation mechanism is in the second orientation.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A system, device, and/or method disclosed herein.

Join the waitlist — get patent alerts

Track US2021228802A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.